Turner Investments’s GSK GSK Stock Holding History

Turner Investments’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-29,736	Closed	-$1.43M	–	237
2016 Q4	$1.43M	Sell	29,736 -14,856	-33%	-$734K	0.58%	62
2016 Q3	$2.4M	Sell	44,592 -6,688	-13%	-$367K	0.8%	42
2016 Q2	$2.78M	Buy	51,280 +5,016	+11%	+$264K	0.87%	39
2016 Q1	$2.35M	Sell	46,264 -64,216	-58%	-$3.2M	0.64%	52
2015 Q4	$5.57M	Buy	110,480 +57,032	+107%	+$2.91M	1.15%	22
2015 Q3	$2.57M	Buy	53,448 +18,024	+51%	+$938K	0.52%	62
2015 Q2	$1.84M	Buy	35,424 +9,440	+36%	+$532K	0.34%	101
2015 Q1	$1.5M	Buy	+25,984	New	+$1.49M	0.27%	117
2013 Q4	–	Sell	-3,248	Closed	-$204K	–	613
2013 Q3	$204K	Sell	3,248 -4,376	-57%	-$282K	﹤0.01%	563
2013 Q2	$476K	Buy	+7,624	New	+$484K	0.01%	516

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Turner Investments's GSK Position: Q1 2017 in Review

Turner Investments sold out of GSK (GSK) in Q1 2017, closing a stake of 29,736 shares — an estimated $1.43M sold.

Turner Investments first reported a position in GSK in Q2 2013 and held it in 10 quarters. The position peaked at $5.57M in Q4 2015. 786 funds tracked by Wall St. Rank hold GSK as of Q1 2017.

Turner Investments reported no remaining GSK position as of Q1 2017 after selling out during the quarter.
Turner Investments sold 29,736 GSK shares in Q1 2017, an estimated $1.43M.
Turner Investments first reported a position in GSK in Q2 2013 and held it in 10 quarters.
Turner Investments's GSK position peaked at $5.57M in Q4 2015.
786 funds tracked by Wall St. Rank held GSK as of Q1 2017.

Based on Turner Investments's 13F filing for Q1 2017, filed 11 May 2017.